Novavax Inc logo

Novavax Inc

NVAX
Healthcare|Biotechnology|USA
$9.33
-0.07 (-0.74%)
Earnings Power
$97.87

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 387.27, 259.13, 348.64, 404.87, 385.1 ], "ebit_estimate": [ -93.19, -23.18, 80.37, 232.88, 214.6 ], "ebitda_estimate": [ -71.01, -42.12, -25.43, null, null ], "net_income_estimate": [ -82.59, -20, 75.66, 199.94, 165.8 ], "per_share_eps_estimate": [ -0.46, -0.07, 0.72, 1.18, 0.98 ], "eps_nri_estimate": [ -0.46, -0.19, 0.55, 0.85, 0.98 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ -3.51, -3.67, null, null, null ], "pretax_income_estimate": [ -91.69, -33.97, 88.41, 244.05, 188.45 ], "operating_cash_flow_per_share_estimate": [ -0.15, -0.95, null, null, null ], "roa_estimate": [ 0.1, -16.2, null, null, null ], "roe_estimate": [ -0.6, 62, null, null, null ], "gross_margin_estimate": [ 87.5, null, null, null, null ], "operating_cash_flow_estimate": [ -24.49, -155.11, null, null, null ], "pettm_estimate": [ 0, 0, 12.96, 7.93, 9.52 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "-32.38", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": -32.38, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 51.1, 99.61, 92.69, 15.31, 22.63, 261.59, 133.43 ], "ebit_estimate": [ -68.54, -15.16, 16.75, -67.35, -61.75, 181.87, 54.58 ], "ebitda_estimate": [ -73.83, 11.16, 21.99, null, null, null, null ], "net_income_estimate": [ -67.02, -14.97, 14.85, -52.13, -37.41, 75.83, 23.18 ], "per_share_eps_estimate": [ -0.39, -0.12, 0.15, -0.32, -0.23, 0.45, 0.14 ], "eps_nri_estimate": [ -0.41, -0.09, 0.09, -0.32, -0.23, 0.45, 0.14 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -67.76, -17.85, -28.78, -59.61, -49.81, 187.75, 66.95 ], "operating_cash_flow_per_share_estimate": [ 1.04, 3.46, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ 169.81, 564.94, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 155.5, 207.33, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "-32.38", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": -32.38, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-06-24 13:04:39
2026-06-18 18:00:30